| pubmed-article:17933531 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C0268563 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:17933531 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:17933531 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:17933531 | pubmed:dateCreated | 2007-11-6 | lld:pubmed |
| pubmed-article:17933531 | pubmed:abstractText | Various 4-phenylpiperidine-benzoxazin-3-ones were synthesized and biologically evaluated as urotensin-II (U-II) receptor antagonists. Compound 12i was identified from in vitro evaluation as a low nanomolar antagonist against both rat and human U-II receptors. This compound showed in vivo efficacy in reversing the ear-flush response induced by U-II in rats. | lld:pubmed |
| pubmed-article:17933531 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17933531 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17933531 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17933531 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17933531 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:LiJianJ | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:MaryanoffBruc... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:SmithCharles... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:KinneyWilliam... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:AlmondHarold... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:GhoshShyamali... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:WangYuanpingY | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:ParryTom JTJ | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:QiJensonJ | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:DamianoBruce... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:MinorLisa KLK | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:LawsonEdward... | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:LuciDiane KDK | lld:pubmed |
| pubmed-article:17933531 | pubmed:author | pubmed-author:HaertleinBarb... | lld:pubmed |
| pubmed-article:17933531 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17933531 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17933531 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17933531 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17933531 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17933531 | pubmed:pagination | 6489-92 | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:meshHeading | pubmed-meshheading:17933531... | lld:pubmed |
| pubmed-article:17933531 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17933531 | pubmed:articleTitle | Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment. | lld:pubmed |
| pubmed-article:17933531 | pubmed:affiliation | Research & Early Development, Johnson & Johnson Pharmaceutical Research & Development, Welsh and McKean Roads, Spring House, PA 19477-0776, USA. | lld:pubmed |
| pubmed-article:17933531 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17933531 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17933531 | lld:chembl |
